Sfoglia per Autore
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study
2007 Campo, Gianluca Calogero; Valgimigli, Marco; Gemmati, Donato; Percoco, Giovanni; Catozzi, Linda; Frangione, Alice; Federici, Federica; Ferrari, F; Tebaldi, Matteo; Luccarelli, S; Parrinello, G; Ferrari, Roberto
Poor response to clopidogrel: current and future options for its management
2010 Campo, Gianluca Calogero; Fileti, L; Valgimigli, M; Tebaldi, M; Cangiano, E; Cavazza, C; Marchesini, J; Ferrari, Roberto
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting
file con accesso da definire2010 M., Valgimigli; Campo, Gianluca Calogero; Tebaldi, Matteo; M., Monti; Gambetti, S.; Scalone, Antonella; G., Parrinello; Ferrari, Roberto; ON BEHALF OF THE FABOLUS SYNCHRO, Investigators
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome
file con accesso da definire2011 Campo, Gianluca Calogero; Parrinello, G.; Ferraresi, Paolo; Lunghi, Barbara; Tebaldi, Matteo; Miccoli, M.; Marchesini, Jlenia; Bernardi, Francesco; Ferrari, Roberto; Valgimigli, Marco
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial.
file con accesso da definire2012 Valgimigli, M; Tebaldi, Matteo; Campo, Gianluca Calogero; Gambetti, S; Bristot, L; Monti, M; Parrinello, G; Ferrari, Roberto; FABOLUS PRO, Investigators
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention
2012 Campo, Gianluca Calogero; Marchesini, J; Fileti, L; Tebaldi, Matteo; Ferrari, Roberto
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial
file con accesso da definire2012 Valgimigli, M; Campo, Gianluca Calogero; Monti, M; Vranckx, P; Percoco, G; Tumscitz, C; Castriota, F; Colombo, F; Tebaldi, Matteo; Fucà, G; Kubbajeh, M; Cangiano, E; Minarelli, M; Scalone, A; Cavazza, C; Frangione, A; Borghesi, M; Marchesini, J; Parrinello, G; Ferrari, Roberto
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients?
file con accesso da definire2012 Campo, Gianluca Calogero; Pavasini, Rita; Pollina, ALBERTO VINCENZO; Fileti, L; Marchesini, J; Tebaldi, Matteo; Ferrari, Roberto
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention
file con accesso da definire2013 Biscaglia, S.; Tebaldi, M.; Vranckx, P.; Campo, G.; Valgimigli, M.
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)
file con accesso da definire2013 Marco, Valgimigli; Borghesi, Marco; Tebaldi, Matteo; Pascal, Vranckx; Giovanni, Parrinello; Ferrari, Roberto; for the PROlonging Dual antiplatelet treatment after Grading stent induced Intimal hyperplasia studY, Investigators
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial
file con accesso da definire2014 Vranckx, P.; Leonardi, S.; Tebaldi, M.; Biscaglia, S.; Parrinello, G.; Rao, S. V.; Mehran, R.; Valgimigli, M.
Seven french radial artery access for PCI: A prospective single-center experience
file con accesso da definire2014 Tumscitz, Carlo; Pirani, Lucia; Tebaldi, Matteo; Campo, Gianluca Calogero; Biscaglia, Simone
Fractional flow reserve: Current applications and overview of the available data
2015 Tebaldi, Matteo; Campo, Gianluca Calogero; Biscaglia, Simone
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates
2015 Valgimigli, M; Patialiakas, A; Thury, A; Mcfadden, E; Colangelo, S; Campo, Gianluca Calogero; Tebaldi, Matteo; Ungi, I; Tondi, S; Roffi, M; Menozzi, A; de Cesare, N; Garbo, R; Meliga, E; Testa, L; Gabriel, Hm; Airoldi, F; Ferlini, M; Liistro, F; Dellavalle, A; Vranckx, P; Briguori, C.
Enhanced stent visualization systems during PCI: A case series and review of literature
file con accesso da definire2015 Biscaglia, S.; Tumscitz, C.; Tebaldi, M.; Andrenacci, E.; Pavasini, R.; Campo, G.; Ferrari, R.
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study
2015 Campo, Gianluca Calogero; Pavasini, Rita; Biscaglia, Simone; Ferri, A; Andrenacci, E; Tebaldi, Matteo; Ferrari, Roberto
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial
file con accesso da definire2015 Crimi, G.; Leonardi, S.; Costa, F.; Ariotti, S.; Tebaldi, M.; Biscaglia, S.; Valgimigli, M.
Fractional flow reserve implementation in daily clinical practice: A European survey
file con accesso da definire2016 Tebaldi, Matteo; Biscaglia, Simone; Pecoraro, Alessandro; Fineschi, Massimo; Campo, Gianluca Calogero
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study)
2016 Tebaldi, Matteo; Biscaglia, Simone; Fineschi, Massimo; Manari, Antonio; Menozzi, Mila; Secco, Gioel Gabrio; Di Lorenzo, Emilio; D'Ascenzo, Fabrizio; Fabbian, Fabio; Tumscitz, Carlo; Ferrari, Roberto; Campo, Gianluca Calogero
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison
2016 Biscaglia, Simone; Campo, Gianluca Calogero; Tebaldi, Matteo; Tumscitz, Carlo; Pavasini, Rita; Fileti, Luca; Secco, Gioel G.; Di Mario, Carlo; Ferrari, Roberto
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study | 2007 | Campo, Gianluca Calogero; Valgimigli, Marco; Gemmati, Donato; Percoco, Giovanni; Catozzi, Linda; ...Frangione, Alice; Federici, Federica; Ferrari, F; Tebaldi, Matteo; Luccarelli, S; Parrinello, G; Ferrari, Roberto | |
Poor response to clopidogrel: current and future options for its management | 2010 | Campo, Gianluca Calogero; Fileti, L; Valgimigli, M; Tebaldi, M; Cangiano, E; Cavazza, C; Marchesi...ni, J; Ferrari, Roberto | |
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting | 2010 | M., Valgimigli; Campo, Gianluca Calogero; Tebaldi, Matteo; M., Monti; Gambetti, S.; Scalone, Anto...nella; G., Parrinello; Ferrari, Roberto; ON BEHALF OF THE FABOLUS SYNCHRO, Investigators | file con accesso da definire |
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome | 2011 | Campo, Gianluca Calogero; Parrinello, G.; Ferraresi, Paolo; Lunghi, Barbara; Tebaldi, Matteo; Mic...coli, M.; Marchesini, Jlenia; Bernardi, Francesco; Ferrari, Roberto; Valgimigli, Marco | file con accesso da definire |
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. | 2012 | Valgimigli, M; Tebaldi, Matteo; Campo, Gianluca Calogero; Gambetti, S; Bristot, L; Monti, M; Parr...inello, G; Ferrari, Roberto; FABOLUS PRO, Investigators | file con accesso da definire |
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention | 2012 | Campo, Gianluca Calogero; Marchesini, J; Fileti, L; Tebaldi, Matteo; Ferrari, Roberto | |
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial | 2012 | Valgimigli, M; Campo, Gianluca Calogero; Monti, M; Vranckx, P; Percoco, G; Tumscitz, C; Castriota..., F; Colombo, F; Tebaldi, Matteo; Fucà, G; Kubbajeh, M; Cangiano, E; Minarelli, M; Scalone, A; Cavazza, C; Frangione, A; Borghesi, M; Marchesini, J; Parrinello, G; Ferrari, Roberto | file con accesso da definire |
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? | 2012 | Campo, Gianluca Calogero; Pavasini, Rita; Pollina, ALBERTO VINCENZO; Fileti, L; Marchesini, J; Te...baldi, Matteo; Ferrari, Roberto | file con accesso da definire |
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention | 2013 | Biscaglia, S.; Tebaldi, M.; Vranckx, P.; Campo, G.; Valgimigli, M. | file con accesso da definire |
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) | 2013 | Marco, Valgimigli; Borghesi, Marco; Tebaldi, Matteo; Pascal, Vranckx; Giovanni, Parrinello; Ferra...ri, Roberto; for the PROlonging Dual antiplatelet treatment after Grading stent induced Intimal hyperplasia studY, Investigators | file con accesso da definire |
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial | 2014 | Vranckx, P.; Leonardi, S.; Tebaldi, M.; Biscaglia, S.; Parrinello, G.; Rao, S. V.; Mehran, R.; Va...lgimigli, M. | file con accesso da definire |
Seven french radial artery access for PCI: A prospective single-center experience | 2014 | Tumscitz, Carlo; Pirani, Lucia; Tebaldi, Matteo; Campo, Gianluca Calogero; Biscaglia, Simone | file con accesso da definire |
Fractional flow reserve: Current applications and overview of the available data | 2015 | Tebaldi, Matteo; Campo, Gianluca Calogero; Biscaglia, Simone | |
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates | 2015 | Valgimigli, M; Patialiakas, A; Thury, A; Mcfadden, E; Colangelo, S; Campo, Gianluca Calogero; Teb...aldi, Matteo; Ungi, I; Tondi, S; Roffi, M; Menozzi, A; de Cesare, N; Garbo, R; Meliga, E; Testa, L; Gabriel, Hm; Airoldi, F; Ferlini, M; Liistro, F; Dellavalle, A; Vranckx, P; Briguori, C. | |
Enhanced stent visualization systems during PCI: A case series and review of literature | 2015 | Biscaglia, S.; Tumscitz, C.; Tebaldi, M.; Andrenacci, E.; Pavasini, R.; Campo, G.; Ferrari, R. | file con accesso da definire |
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study | 2015 | Campo, Gianluca Calogero; Pavasini, Rita; Biscaglia, Simone; Ferri, A; Andrenacci, E; Tebaldi, Ma...tteo; Ferrari, Roberto | |
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial | 2015 | Crimi, G.; Leonardi, S.; Costa, F.; Ariotti, S.; Tebaldi, M.; Biscaglia, S.; Valgimigli, M. | file con accesso da definire |
Fractional flow reserve implementation in daily clinical practice: A European survey | 2016 | Tebaldi, Matteo; Biscaglia, Simone; Pecoraro, Alessandro; Fineschi, Massimo; Campo, Gianluca Calo...gero | file con accesso da definire |
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) | 2016 | Tebaldi, Matteo; Biscaglia, Simone; Fineschi, Massimo; Manari, Antonio; Menozzi, Mila; Secco, Gio...el Gabrio; Di Lorenzo, Emilio; D'Ascenzo, Fabrizio; Fabbian, Fabio; Tumscitz, Carlo; Ferrari, Roberto; Campo, Gianluca Calogero | |
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison | 2016 | Biscaglia, Simone; Campo, Gianluca Calogero; Tebaldi, Matteo; Tumscitz, Carlo; Pavasini, Rita; Fi...leti, Luca; Secco, Gioel G.; Di Mario, Carlo; Ferrari, Roberto |
Legenda icone
- file ad accesso aperto
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile